nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—PTGER1—breast cancer	0.594	1	CbGaD
Bimatoprost—AKR1C3—Doxorubicin—breast cancer	0.0977	1	CbGbCtD
Bimatoprost—PTGFR—corpus luteum—breast cancer	0.0202	0.33	CbGeAlD
Bimatoprost—PTGER3—mammary gland—breast cancer	0.00391	0.0639	CbGeAlD
Bimatoprost—PTGFR—nipple—breast cancer	0.00259	0.0423	CbGeAlD
Bimatoprost—AKR1C3—nipple—breast cancer	0.0021	0.0344	CbGeAlD
Bimatoprost—PTGER1—female reproductive system—breast cancer	0.00185	0.0302	CbGeAlD
Bimatoprost—PTGER3—uterus—breast cancer	0.0018	0.0294	CbGeAlD
Bimatoprost—PTGER3—adipose tissue—breast cancer	0.00176	0.0288	CbGeAlD
Bimatoprost—PTGER1—female gonad—breast cancer	0.00168	0.0275	CbGeAlD
Bimatoprost—PTGER3—female reproductive system—breast cancer	0.00162	0.0265	CbGeAlD
Bimatoprost—PTGER3—adrenal gland—breast cancer	0.00158	0.0258	CbGeAlD
Bimatoprost—PTGER1—endocrine gland—breast cancer	0.00156	0.0255	CbGeAlD
Bimatoprost—PTGER3—female gonad—breast cancer	0.00147	0.0241	CbGeAlD
Bimatoprost—Carboprost Tromethamine—PTGER1—breast cancer	0.00145	0.247	CrCbGaD
Bimatoprost—PTGFR—uterus—breast cancer	0.00144	0.0235	CbGeAlD
Bimatoprost—PTGFR—adipose tissue—breast cancer	0.00141	0.023	CbGeAlD
Bimatoprost—PTGER3—endocrine gland—breast cancer	0.00137	0.0224	CbGeAlD
Bimatoprost—PTGFR—female reproductive system—breast cancer	0.00129	0.0211	CbGeAlD
Bimatoprost—AKR1C3—endometrium—breast cancer	0.00127	0.0207	CbGeAlD
Bimatoprost—PTGFR—adrenal gland—breast cancer	0.00126	0.0206	CbGeAlD
Bimatoprost—PTGFR—female gonad—breast cancer	0.00118	0.0192	CbGeAlD
Bimatoprost—AKR1C3—uterus—breast cancer	0.00117	0.0191	CbGeAlD
Bimatoprost—AKR1C3—Vincristine—Vinorelbine—breast cancer	0.00116	0.384	CbGdCrCtD
Bimatoprost—AKR1C3—pituitary gland—breast cancer	0.00115	0.0188	CbGeAlD
Bimatoprost—AKR1C3—adipose tissue—breast cancer	0.00114	0.0187	CbGeAlD
Bimatoprost—PTGFR—endocrine gland—breast cancer	0.00109	0.0179	CbGeAlD
Bimatoprost—AKR1C3—adrenal gland—breast cancer	0.00103	0.0168	CbGeAlD
Bimatoprost—Epoprostenol—PTGER1—breast cancer	0.00101	0.171	CrCbGaD
Bimatoprost—AKR1C3—bone marrow—breast cancer	0.000993	0.0162	CbGeAlD
Bimatoprost—AKR1C3—female gonad—breast cancer	0.000957	0.0156	CbGeAlD
Bimatoprost—PTGER3—lymph node—breast cancer	0.000947	0.0155	CbGeAlD
Bimatoprost—Iloprost—PTGER1—breast cancer	0.000936	0.159	CrCbGaD
Bimatoprost—AKR1C3—Vinblastine—Vinorelbine—breast cancer	0.000934	0.309	CbGdCrCtD
Bimatoprost—AKR1C3—Vincristine—Vinblastine—breast cancer	0.000928	0.307	CbGdCrCtD
Bimatoprost—PTGFR—lymph node—breast cancer	0.000757	0.0124	CbGeAlD
Bimatoprost—AKR1C3—lymph node—breast cancer	0.000615	0.0101	CbGeAlD
Bimatoprost—Dinoprost Tromethamine—PTGER1—breast cancer	0.000552	0.0939	CrCbGaD
Bimatoprost—Iloprost—PDE4D—breast cancer	0.000433	0.0736	CrCbGaD
Bimatoprost—Dinoprostone—PTGER1—breast cancer	0.000425	0.0722	CrCbGaD
Bimatoprost—Dinoprost Tromethamine—HPGDS—breast cancer	0.000376	0.0638	CrCbGaD
Bimatoprost—Dinoprostone—HPGDS—breast cancer	0.000289	0.0491	CrCbGaD
Bimatoprost—Dinoprostone—SLCO1B1—breast cancer	0.000194	0.0329	CrCbGaD
Bimatoprost—Tafluprost—PTGS2—breast cancer	0.000131	0.0223	CrCbGaD
Bimatoprost—Dinoprostone—CYP19A1—breast cancer	8.97e-05	0.0153	CrCbGaD
Bimatoprost—Dyspepsia—Mitoxantrone—breast cancer	7.4e-05	0.000545	CcSEcCtD
Bimatoprost—Diplopia—Doxorubicin—breast cancer	7.38e-05	0.000543	CcSEcCtD
Bimatoprost—Mediastinal disorder—Docetaxel—breast cancer	7.37e-05	0.000543	CcSEcCtD
Bimatoprost—Asthma—Methotrexate—breast cancer	7.36e-05	0.000542	CcSEcCtD
Bimatoprost—Liver function test abnormal—Epirubicin—breast cancer	7.36e-05	0.000542	CcSEcCtD
Bimatoprost—Rash—Melphalan—breast cancer	7.35e-05	0.000542	CcSEcCtD
Bimatoprost—Dermatitis—Melphalan—breast cancer	7.35e-05	0.000541	CcSEcCtD
Bimatoprost—Cough—Paclitaxel—breast cancer	7.33e-05	0.00054	CcSEcCtD
Bimatoprost—Asthenia—Vinorelbine—breast cancer	7.31e-05	0.000538	CcSEcCtD
Bimatoprost—Dry skin—Epirubicin—breast cancer	7.31e-05	0.000538	CcSEcCtD
Bimatoprost—Dyspnoea—Gemcitabine—breast cancer	7.3e-05	0.000537	CcSEcCtD
Bimatoprost—Nausea—Vinblastine—breast cancer	7.28e-05	0.000536	CcSEcCtD
Bimatoprost—Insomnia—Fluorouracil—breast cancer	7.28e-05	0.000536	CcSEcCtD
Bimatoprost—Somnolence—Gemcitabine—breast cancer	7.28e-05	0.000536	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Irinotecan—breast cancer	7.26e-05	0.000534	CcSEcCtD
Bimatoprost—Hypertension—Paclitaxel—breast cancer	7.25e-05	0.000534	CcSEcCtD
Bimatoprost—Pruritus—Vinorelbine—breast cancer	7.21e-05	0.000531	CcSEcCtD
Bimatoprost—Pain—Mitoxantrone—breast cancer	7.19e-05	0.000529	CcSEcCtD
Bimatoprost—Pain—Irinotecan—breast cancer	7.19e-05	0.000529	CcSEcCtD
Bimatoprost—Angiopathy—Capecitabine—breast cancer	7.18e-05	0.000529	CcSEcCtD
Bimatoprost—Dyspnoea—Fluorouracil—breast cancer	7.18e-05	0.000528	CcSEcCtD
Bimatoprost—Rash—Goserelin—breast cancer	7.17e-05	0.000528	CcSEcCtD
Bimatoprost—Dermatitis—Goserelin—breast cancer	7.17e-05	0.000528	CcSEcCtD
Bimatoprost—Somnolence—Fluorouracil—breast cancer	7.16e-05	0.000527	CcSEcCtD
Bimatoprost—Chest pain—Paclitaxel—breast cancer	7.15e-05	0.000527	CcSEcCtD
Bimatoprost—Mediastinal disorder—Capecitabine—breast cancer	7.14e-05	0.000525	CcSEcCtD
Bimatoprost—Nasopharyngitis—Epirubicin—breast cancer	7.13e-05	0.000525	CcSEcCtD
Bimatoprost—Headache—Goserelin—breast cancer	7.13e-05	0.000525	CcSEcCtD
Bimatoprost—Anxiety—Paclitaxel—breast cancer	7.13e-05	0.000525	CcSEcCtD
Bimatoprost—Erythema—Docetaxel—breast cancer	7.12e-05	0.000524	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	7.1e-05	0.000523	CcSEcCtD
Bimatoprost—Dyspepsia—Fluorouracil—breast cancer	7.09e-05	0.000522	CcSEcCtD
Bimatoprost—Nausea—Tamoxifen—breast cancer	7.08e-05	0.000521	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Gemcitabine—breast cancer	7.07e-05	0.00052	CcSEcCtD
Bimatoprost—Pain—Gemcitabine—breast cancer	7e-05	0.000516	CcSEcCtD
Bimatoprost—Dry mouth—Paclitaxel—breast cancer	6.99e-05	0.000515	CcSEcCtD
Bimatoprost—Asthenia—Thiotepa—breast cancer	6.98e-05	0.000514	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Fluorouracil—breast cancer	6.95e-05	0.000512	CcSEcCtD
Bimatoprost—Nausea—Melphalan—breast cancer	6.93e-05	0.00051	CcSEcCtD
Bimatoprost—Erythema—Capecitabine—breast cancer	6.89e-05	0.000508	CcSEcCtD
Bimatoprost—Asthma—Epirubicin—breast cancer	6.89e-05	0.000507	CcSEcCtD
Bimatoprost—Pruritus—Thiotepa—breast cancer	6.89e-05	0.000507	CcSEcCtD
Bimatoprost—Pain—Fluorouracil—breast cancer	6.88e-05	0.000507	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Methotrexate—breast cancer	6.84e-05	0.000504	CcSEcCtD
Bimatoprost—Liver function test abnormal—Doxorubicin—breast cancer	6.81e-05	0.000502	CcSEcCtD
Bimatoprost—Infection—Paclitaxel—breast cancer	6.81e-05	0.000501	CcSEcCtD
Bimatoprost—Dry skin—Doxorubicin—breast cancer	6.76e-05	0.000498	CcSEcCtD
Bimatoprost—Nausea—Goserelin—breast cancer	6.76e-05	0.000498	CcSEcCtD
Bimatoprost—Dizziness—Vinorelbine—breast cancer	6.74e-05	0.000496	CcSEcCtD
Bimatoprost—Nervous system disorder—Paclitaxel—breast cancer	6.72e-05	0.000495	CcSEcCtD
Bimatoprost—Skin disorder—Paclitaxel—breast cancer	6.66e-05	0.00049	CcSEcCtD
Bimatoprost—Bronchitis—Epirubicin—breast cancer	6.63e-05	0.000488	CcSEcCtD
Bimatoprost—Nasopharyngitis—Doxorubicin—breast cancer	6.6e-05	0.000486	CcSEcCtD
Bimatoprost—Depression—Methotrexate—breast cancer	6.55e-05	0.000482	CcSEcCtD
Bimatoprost—Vision blurred—Capecitabine—breast cancer	6.5e-05	0.000478	CcSEcCtD
Bimatoprost—Dizziness—Thiotepa—breast cancer	6.44e-05	0.000474	CcSEcCtD
Bimatoprost—Rash—Vinorelbine—breast cancer	6.43e-05	0.000473	CcSEcCtD
Bimatoprost—Dermatitis—Vinorelbine—breast cancer	6.42e-05	0.000473	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Epirubicin—breast cancer	6.4e-05	0.000472	CcSEcCtD
Bimatoprost—Headache—Vinorelbine—breast cancer	6.38e-05	0.00047	CcSEcCtD
Bimatoprost—Asthma—Doxorubicin—breast cancer	6.38e-05	0.00047	CcSEcCtD
Bimatoprost—Palpitations—Docetaxel—breast cancer	6.29e-05	0.000463	CcSEcCtD
Bimatoprost—Cough—Docetaxel—breast cancer	6.21e-05	0.000457	CcSEcCtD
Bimatoprost—Insomnia—Paclitaxel—breast cancer	6.2e-05	0.000457	CcSEcCtD
Bimatoprost—Vertigo—Capecitabine—breast cancer	6.19e-05	0.000456	CcSEcCtD
Bimatoprost—Hypertension—Docetaxel—breast cancer	6.15e-05	0.000453	CcSEcCtD
Bimatoprost—Rash—Thiotepa—breast cancer	6.14e-05	0.000452	CcSEcCtD
Bimatoprost—Bronchitis—Doxorubicin—breast cancer	6.13e-05	0.000452	CcSEcCtD
Bimatoprost—Dermatitis—Thiotepa—breast cancer	6.13e-05	0.000451	CcSEcCtD
Bimatoprost—Dyspnoea—Paclitaxel—breast cancer	6.11e-05	0.00045	CcSEcCtD
Bimatoprost—Headache—Thiotepa—breast cancer	6.1e-05	0.000449	CcSEcCtD
Bimatoprost—Somnolence—Paclitaxel—breast cancer	6.09e-05	0.000449	CcSEcCtD
Bimatoprost—Palpitations—Capecitabine—breast cancer	6.09e-05	0.000449	CcSEcCtD
Bimatoprost—Chest pain—Docetaxel—breast cancer	6.06e-05	0.000446	CcSEcCtD
Bimatoprost—Nausea—Vinorelbine—breast cancer	6.05e-05	0.000446	CcSEcCtD
Bimatoprost—Dyspepsia—Paclitaxel—breast cancer	6.03e-05	0.000444	CcSEcCtD
Bimatoprost—Asthenia—Mitoxantrone—breast cancer	6.03e-05	0.000444	CcSEcCtD
Bimatoprost—Asthenia—Irinotecan—breast cancer	6.03e-05	0.000444	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	6.02e-05	0.000443	CcSEcCtD
Bimatoprost—Cough—Capecitabine—breast cancer	6.01e-05	0.000443	CcSEcCtD
Bimatoprost—Hypertension—Capecitabine—breast cancer	5.95e-05	0.000438	CcSEcCtD
Bimatoprost—Dry mouth—Docetaxel—breast cancer	5.93e-05	0.000436	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Doxorubicin—breast cancer	5.93e-05	0.000436	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Paclitaxel—breast cancer	5.92e-05	0.000436	CcSEcCtD
Bimatoprost—Asthenia—Gemcitabine—breast cancer	5.87e-05	0.000433	CcSEcCtD
Bimatoprost—Chest pain—Capecitabine—breast cancer	5.87e-05	0.000432	CcSEcCtD
Bimatoprost—Pain—Paclitaxel—breast cancer	5.86e-05	0.000432	CcSEcCtD
Bimatoprost—Pharyngitis—Methotrexate—breast cancer	5.85e-05	0.000431	CcSEcCtD
Bimatoprost—Anxiety—Capecitabine—breast cancer	5.85e-05	0.000431	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	5.83e-05	0.000429	CcSEcCtD
Bimatoprost—Pruritus—Gemcitabine—breast cancer	5.79e-05	0.000427	CcSEcCtD
Bimatoprost—Nausea—Thiotepa—breast cancer	5.78e-05	0.000426	CcSEcCtD
Bimatoprost—Infection—Docetaxel—breast cancer	5.77e-05	0.000425	CcSEcCtD
Bimatoprost—Sinusitis—Epirubicin—breast cancer	5.76e-05	0.000424	CcSEcCtD
Bimatoprost—Dry mouth—Capecitabine—breast cancer	5.74e-05	0.000423	CcSEcCtD
Bimatoprost—Nervous system disorder—Docetaxel—breast cancer	5.7e-05	0.00042	CcSEcCtD
Bimatoprost—Pruritus—Fluorouracil—breast cancer	5.7e-05	0.000419	CcSEcCtD
Bimatoprost—Visual impairment—Methotrexate—breast cancer	5.68e-05	0.000418	CcSEcCtD
Bimatoprost—Skin disorder—Docetaxel—breast cancer	5.64e-05	0.000416	CcSEcCtD
Bimatoprost—Infection—Capecitabine—breast cancer	5.59e-05	0.000412	CcSEcCtD
Bimatoprost—Dizziness—Irinotecan—breast cancer	5.56e-05	0.000409	CcSEcCtD
Bimatoprost—Rhinitis—Epirubicin—breast cancer	5.53e-05	0.000407	CcSEcCtD
Bimatoprost—Nervous system disorder—Capecitabine—breast cancer	5.52e-05	0.000406	CcSEcCtD
Bimatoprost—Eye disorder—Methotrexate—breast cancer	5.51e-05	0.000406	CcSEcCtD
Bimatoprost—Pharyngitis—Epirubicin—breast cancer	5.47e-05	0.000403	CcSEcCtD
Bimatoprost—Skin disorder—Capecitabine—breast cancer	5.46e-05	0.000402	CcSEcCtD
Bimatoprost—Oedema peripheral—Epirubicin—breast cancer	5.43e-05	0.0004	CcSEcCtD
Bimatoprost—Connective tissue disorder—Epirubicin—breast cancer	5.42e-05	0.000399	CcSEcCtD
Bimatoprost—Angiopathy—Methotrexate—breast cancer	5.35e-05	0.000394	CcSEcCtD
Bimatoprost—Sinusitis—Doxorubicin—breast cancer	5.33e-05	0.000393	CcSEcCtD
Bimatoprost—Dizziness—Fluorouracil—breast cancer	5.32e-05	0.000392	CcSEcCtD
Bimatoprost—Visual impairment—Epirubicin—breast cancer	5.32e-05	0.000391	CcSEcCtD
Bimatoprost—Mediastinal disorder—Methotrexate—breast cancer	5.31e-05	0.000391	CcSEcCtD
Bimatoprost—Rash—Mitoxantrone—breast cancer	5.3e-05	0.00039	CcSEcCtD
Bimatoprost—Rash—Irinotecan—breast cancer	5.3e-05	0.00039	CcSEcCtD
Bimatoprost—Dermatitis—Irinotecan—breast cancer	5.29e-05	0.00039	CcSEcCtD
Bimatoprost—Dermatitis—Mitoxantrone—breast cancer	5.29e-05	0.00039	CcSEcCtD
Bimatoprost—Headache—Mitoxantrone—breast cancer	5.27e-05	0.000388	CcSEcCtD
Bimatoprost—Headache—Irinotecan—breast cancer	5.27e-05	0.000388	CcSEcCtD
Bimatoprost—Insomnia—Docetaxel—breast cancer	5.25e-05	0.000387	CcSEcCtD
Bimatoprost—Dyspnoea—Docetaxel—breast cancer	5.18e-05	0.000381	CcSEcCtD
Bimatoprost—Somnolence—Docetaxel—breast cancer	5.17e-05	0.00038	CcSEcCtD
Bimatoprost—Rash—Gemcitabine—breast cancer	5.16e-05	0.00038	CcSEcCtD
Bimatoprost—Dermatitis—Gemcitabine—breast cancer	5.16e-05	0.00038	CcSEcCtD
Bimatoprost—Eye disorder—Epirubicin—breast cancer	5.15e-05	0.00038	CcSEcCtD
Bimatoprost—Erythema—Methotrexate—breast cancer	5.13e-05	0.000378	CcSEcCtD
Bimatoprost—Headache—Gemcitabine—breast cancer	5.13e-05	0.000378	CcSEcCtD
Bimatoprost—Rhinitis—Doxorubicin—breast cancer	5.12e-05	0.000377	CcSEcCtD
Bimatoprost—Dyspepsia—Docetaxel—breast cancer	5.11e-05	0.000377	CcSEcCtD
Bimatoprost—Insomnia—Capecitabine—breast cancer	5.09e-05	0.000375	CcSEcCtD
Bimatoprost—Rash—Fluorouracil—breast cancer	5.08e-05	0.000374	CcSEcCtD
Bimatoprost—Dermatitis—Fluorouracil—breast cancer	5.07e-05	0.000373	CcSEcCtD
Bimatoprost—Pharyngitis—Doxorubicin—breast cancer	5.07e-05	0.000373	CcSEcCtD
Bimatoprost—Headache—Fluorouracil—breast cancer	5.04e-05	0.000371	CcSEcCtD
Bimatoprost—Oedema peripheral—Doxorubicin—breast cancer	5.03e-05	0.00037	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Docetaxel—breast cancer	5.02e-05	0.000369	CcSEcCtD
Bimatoprost—Connective tissue disorder—Doxorubicin—breast cancer	5.02e-05	0.000369	CcSEcCtD
Bimatoprost—Dyspnoea—Capecitabine—breast cancer	5.02e-05	0.000369	CcSEcCtD
Bimatoprost—Angiopathy—Epirubicin—breast cancer	5e-05	0.000369	CcSEcCtD
Bimatoprost—Nausea—Mitoxantrone—breast cancer	4.99e-05	0.000368	CcSEcCtD
Bimatoprost—Nausea—Irinotecan—breast cancer	4.99e-05	0.000368	CcSEcCtD
Bimatoprost—Mediastinal disorder—Epirubicin—breast cancer	4.97e-05	0.000366	CcSEcCtD
Bimatoprost—Pain—Docetaxel—breast cancer	4.97e-05	0.000366	CcSEcCtD
Bimatoprost—Dyspepsia—Capecitabine—breast cancer	4.95e-05	0.000365	CcSEcCtD
Bimatoprost—Visual impairment—Doxorubicin—breast cancer	4.92e-05	0.000362	CcSEcCtD
Bimatoprost—Asthenia—Paclitaxel—breast cancer	4.92e-05	0.000362	CcSEcCtD
Bimatoprost—Nausea—Gemcitabine—breast cancer	4.86e-05	0.000358	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Capecitabine—breast cancer	4.86e-05	0.000358	CcSEcCtD
Bimatoprost—Pruritus—Paclitaxel—breast cancer	4.85e-05	0.000357	CcSEcCtD
Bimatoprost—Vision blurred—Methotrexate—breast cancer	4.84e-05	0.000356	CcSEcCtD
Bimatoprost—Pain—Capecitabine—breast cancer	4.81e-05	0.000354	CcSEcCtD
Bimatoprost—Erythema—Epirubicin—breast cancer	4.8e-05	0.000354	CcSEcCtD
Bimatoprost—Nausea—Fluorouracil—breast cancer	4.78e-05	0.000352	CcSEcCtD
Bimatoprost—Eye disorder—Doxorubicin—breast cancer	4.77e-05	0.000351	CcSEcCtD
Bimatoprost—Tension—Epirubicin—breast cancer	4.71e-05	0.000347	CcSEcCtD
Bimatoprost—Nervousness—Epirubicin—breast cancer	4.66e-05	0.000343	CcSEcCtD
Bimatoprost—Angiopathy—Doxorubicin—breast cancer	4.63e-05	0.000341	CcSEcCtD
Bimatoprost—Vertigo—Methotrexate—breast cancer	4.61e-05	0.000339	CcSEcCtD
Bimatoprost—Mediastinal disorder—Doxorubicin—breast cancer	4.6e-05	0.000339	CcSEcCtD
Bimatoprost—Dizziness—Paclitaxel—breast cancer	4.53e-05	0.000334	CcSEcCtD
Bimatoprost—Vision blurred—Epirubicin—breast cancer	4.53e-05	0.000333	CcSEcCtD
Bimatoprost—Cough—Methotrexate—breast cancer	4.48e-05	0.00033	CcSEcCtD
Bimatoprost—Erythema—Doxorubicin—breast cancer	4.44e-05	0.000327	CcSEcCtD
Bimatoprost—Chest pain—Methotrexate—breast cancer	4.37e-05	0.000322	CcSEcCtD
Bimatoprost—Tension—Doxorubicin—breast cancer	4.36e-05	0.000321	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.34e-05	0.000319	CcSEcCtD
Bimatoprost—Rash—Paclitaxel—breast cancer	4.32e-05	0.000318	CcSEcCtD
Bimatoprost—Dermatitis—Paclitaxel—breast cancer	4.32e-05	0.000318	CcSEcCtD
Bimatoprost—Nervousness—Doxorubicin—breast cancer	4.32e-05	0.000318	CcSEcCtD
Bimatoprost—Vertigo—Epirubicin—breast cancer	4.31e-05	0.000318	CcSEcCtD
Bimatoprost—Headache—Paclitaxel—breast cancer	4.29e-05	0.000316	CcSEcCtD
Bimatoprost—Palpitations—Epirubicin—breast cancer	4.24e-05	0.000312	CcSEcCtD
Bimatoprost—Cough—Epirubicin—breast cancer	4.19e-05	0.000309	CcSEcCtD
Bimatoprost—Vision blurred—Doxorubicin—breast cancer	4.19e-05	0.000308	CcSEcCtD
Bimatoprost—Asthenia—Docetaxel—breast cancer	4.17e-05	0.000307	CcSEcCtD
Bimatoprost—Infection—Methotrexate—breast cancer	4.16e-05	0.000306	CcSEcCtD
Bimatoprost—Hypertension—Epirubicin—breast cancer	4.15e-05	0.000305	CcSEcCtD
Bimatoprost—Pruritus—Docetaxel—breast cancer	4.11e-05	0.000303	CcSEcCtD
Bimatoprost—Nervous system disorder—Methotrexate—breast cancer	4.11e-05	0.000302	CcSEcCtD
Bimatoprost—Chest pain—Epirubicin—breast cancer	4.09e-05	0.000301	CcSEcCtD
Bimatoprost—Anxiety—Epirubicin—breast cancer	4.07e-05	0.0003	CcSEcCtD
Bimatoprost—Nausea—Paclitaxel—breast cancer	4.07e-05	0.0003	CcSEcCtD
Bimatoprost—Skin disorder—Methotrexate—breast cancer	4.07e-05	0.0003	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.06e-05	0.000299	CcSEcCtD
Bimatoprost—Asthenia—Capecitabine—breast cancer	4.04e-05	0.000297	CcSEcCtD
Bimatoprost—Dry mouth—Epirubicin—breast cancer	4e-05	0.000294	CcSEcCtD
Bimatoprost—Vertigo—Doxorubicin—breast cancer	3.99e-05	0.000294	CcSEcCtD
Bimatoprost—Pruritus—Capecitabine—breast cancer	3.98e-05	0.000293	CcSEcCtD
Bimatoprost—Palpitations—Doxorubicin—breast cancer	3.93e-05	0.000289	CcSEcCtD
Bimatoprost—Infection—Epirubicin—breast cancer	3.89e-05	0.000287	CcSEcCtD
Bimatoprost—Cough—Doxorubicin—breast cancer	3.88e-05	0.000285	CcSEcCtD
Bimatoprost—Nervous system disorder—Epirubicin—breast cancer	3.84e-05	0.000283	CcSEcCtD
Bimatoprost—Dizziness—Docetaxel—breast cancer	3.84e-05	0.000283	CcSEcCtD
Bimatoprost—Hypertension—Doxorubicin—breast cancer	3.84e-05	0.000282	CcSEcCtD
Bimatoprost—Skin disorder—Epirubicin—breast cancer	3.81e-05	0.00028	CcSEcCtD
Bimatoprost—Insomnia—Methotrexate—breast cancer	3.79e-05	0.000279	CcSEcCtD
Bimatoprost—Chest pain—Doxorubicin—breast cancer	3.78e-05	0.000279	CcSEcCtD
Bimatoprost—Anxiety—Doxorubicin—breast cancer	3.77e-05	0.000278	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.76e-05	0.000277	CcSEcCtD
Bimatoprost—Dyspnoea—Methotrexate—breast cancer	3.73e-05	0.000275	CcSEcCtD
Bimatoprost—Somnolence—Methotrexate—breast cancer	3.72e-05	0.000274	CcSEcCtD
Bimatoprost—Dizziness—Capecitabine—breast cancer	3.72e-05	0.000274	CcSEcCtD
Bimatoprost—Dry mouth—Doxorubicin—breast cancer	3.7e-05	0.000272	CcSEcCtD
Bimatoprost—Dyspepsia—Methotrexate—breast cancer	3.69e-05	0.000271	CcSEcCtD
Bimatoprost—Rash—Docetaxel—breast cancer	3.66e-05	0.00027	CcSEcCtD
Bimatoprost—Dermatitis—Docetaxel—breast cancer	3.66e-05	0.000269	CcSEcCtD
Bimatoprost—Headache—Docetaxel—breast cancer	3.64e-05	0.000268	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Methotrexate—breast cancer	3.62e-05	0.000266	CcSEcCtD
Bimatoprost—Infection—Doxorubicin—breast cancer	3.6e-05	0.000265	CcSEcCtD
Bimatoprost—Pain—Methotrexate—breast cancer	3.58e-05	0.000264	CcSEcCtD
Bimatoprost—Nervous system disorder—Doxorubicin—breast cancer	3.56e-05	0.000262	CcSEcCtD
Bimatoprost—Rash—Capecitabine—breast cancer	3.55e-05	0.000261	CcSEcCtD
Bimatoprost—Insomnia—Epirubicin—breast cancer	3.54e-05	0.000261	CcSEcCtD
Bimatoprost—Dermatitis—Capecitabine—breast cancer	3.54e-05	0.000261	CcSEcCtD
Bimatoprost—Headache—Capecitabine—breast cancer	3.52e-05	0.000259	CcSEcCtD
Bimatoprost—Skin disorder—Doxorubicin—breast cancer	3.52e-05	0.000259	CcSEcCtD
Bimatoprost—Dyspnoea—Epirubicin—breast cancer	3.49e-05	0.000257	CcSEcCtD
Bimatoprost—Somnolence—Epirubicin—breast cancer	3.48e-05	0.000257	CcSEcCtD
Bimatoprost—Nausea—Docetaxel—breast cancer	3.45e-05	0.000254	CcSEcCtD
Bimatoprost—Dyspepsia—Epirubicin—breast cancer	3.45e-05	0.000254	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Epirubicin—breast cancer	3.38e-05	0.000249	CcSEcCtD
Bimatoprost—Pain—Epirubicin—breast cancer	3.35e-05	0.000247	CcSEcCtD
Bimatoprost—Nausea—Capecitabine—breast cancer	3.34e-05	0.000246	CcSEcCtD
Bimatoprost—Insomnia—Doxorubicin—breast cancer	3.28e-05	0.000241	CcSEcCtD
Bimatoprost—Dyspnoea—Doxorubicin—breast cancer	3.23e-05	0.000238	CcSEcCtD
Bimatoprost—Somnolence—Doxorubicin—breast cancer	3.22e-05	0.000237	CcSEcCtD
Bimatoprost—Dyspepsia—Doxorubicin—breast cancer	3.19e-05	0.000235	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Doxorubicin—breast cancer	3.13e-05	0.000231	CcSEcCtD
Bimatoprost—Pain—Doxorubicin—breast cancer	3.1e-05	0.000228	CcSEcCtD
Bimatoprost—Asthenia—Methotrexate—breast cancer	3e-05	0.000221	CcSEcCtD
Bimatoprost—Pruritus—Methotrexate—breast cancer	2.96e-05	0.000218	CcSEcCtD
Bimatoprost—Asthenia—Epirubicin—breast cancer	2.81e-05	0.000207	CcSEcCtD
Bimatoprost—Pruritus—Epirubicin—breast cancer	2.77e-05	0.000204	CcSEcCtD
Bimatoprost—Dizziness—Methotrexate—breast cancer	2.77e-05	0.000204	CcSEcCtD
Bimatoprost—Rash—Methotrexate—breast cancer	2.64e-05	0.000194	CcSEcCtD
Bimatoprost—Dermatitis—Methotrexate—breast cancer	2.64e-05	0.000194	CcSEcCtD
Bimatoprost—Headache—Methotrexate—breast cancer	2.62e-05	0.000193	CcSEcCtD
Bimatoprost—Asthenia—Doxorubicin—breast cancer	2.6e-05	0.000192	CcSEcCtD
Bimatoprost—Dizziness—Epirubicin—breast cancer	2.59e-05	0.000191	CcSEcCtD
Bimatoprost—Pruritus—Doxorubicin—breast cancer	2.57e-05	0.000189	CcSEcCtD
Bimatoprost—Nausea—Methotrexate—breast cancer	2.49e-05	0.000183	CcSEcCtD
Bimatoprost—Rash—Epirubicin—breast cancer	2.47e-05	0.000182	CcSEcCtD
Bimatoprost—Dermatitis—Epirubicin—breast cancer	2.47e-05	0.000182	CcSEcCtD
Bimatoprost—Headache—Epirubicin—breast cancer	2.46e-05	0.000181	CcSEcCtD
Bimatoprost—Dizziness—Doxorubicin—breast cancer	2.4e-05	0.000177	CcSEcCtD
Bimatoprost—Nausea—Epirubicin—breast cancer	2.33e-05	0.000171	CcSEcCtD
Bimatoprost—Rash—Doxorubicin—breast cancer	2.29e-05	0.000168	CcSEcCtD
Bimatoprost—Dermatitis—Doxorubicin—breast cancer	2.28e-05	0.000168	CcSEcCtD
Bimatoprost—Headache—Doxorubicin—breast cancer	2.27e-05	0.000167	CcSEcCtD
Bimatoprost—Nausea—Doxorubicin—breast cancer	2.15e-05	0.000159	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—ERBB3—breast cancer	1.21e-05	0.000118	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FGFR2—breast cancer	1.2e-05	0.000118	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL2—breast cancer	1.19e-05	0.000116	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TERT—breast cancer	1.18e-05	0.000115	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CD—breast cancer	1.18e-05	0.000115	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.18e-05	0.000115	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SPP1—breast cancer	1.18e-05	0.000115	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CD—breast cancer	1.17e-05	0.000114	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SERPINE1—breast cancer	1.17e-05	0.000114	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ERBB3—breast cancer	1.16e-05	0.000114	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FGFR2—breast cancer	1.16e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL2—breast cancer	1.16e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PIK3CA—breast cancer	1.16e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SERPINE1—breast cancer	1.16e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TERT—breast cancer	1.16e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FGFR1—breast cancer	1.15e-05	0.000112	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—KRAS—breast cancer	1.15e-05	0.000112	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HIF1A—breast cancer	1.13e-05	0.00011	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CG—breast cancer	1.12e-05	0.00011	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FGFR1—breast cancer	1.12e-05	0.00011	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TERT—breast cancer	1.12e-05	0.000109	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOS3—breast cancer	1.11e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HIF1A—breast cancer	1.11e-05	0.000108	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NOS3—breast cancer	1.1e-05	0.000108	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LEP—breast cancer	1.1e-05	0.000108	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CAV1—breast cancer	1.09e-05	0.000107	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FGFR1—breast cancer	1.08e-05	0.000106	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KDR—breast cancer	1.08e-05	0.000105	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LEP—breast cancer	1.08e-05	0.000105	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CAV1—breast cancer	1.07e-05	0.000104	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HIF1A—breast cancer	1.07e-05	0.000104	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KDR—breast cancer	1.06e-05	0.000103	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MDM2—breast cancer	1.06e-05	0.000103	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—RAF1—breast cancer	1.05e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ESR1—breast cancer	1.05e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PIK3CA—breast cancer	1.05e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MDM2—breast cancer	1.05e-05	0.000102	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RAF1—breast cancer	1.04e-05	0.000102	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ERBB2—breast cancer	1.04e-05	0.000102	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LEP—breast cancer	1.04e-05	0.000102	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FN1—breast cancer	1.04e-05	0.000102	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RELA—breast cancer	1.04e-05	0.000102	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ERBB2—breast cancer	1.03e-05	0.000101	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CAV1—breast cancer	1.03e-05	0.000101	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ESR1—breast cancer	1.03e-05	0.000101	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CB—breast cancer	1.03e-05	0.0001	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MTOR—breast cancer	1.03e-05	0.0001	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NFKBIA—breast cancer	1.03e-05	0.0001	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CD4—breast cancer	1.03e-05	0.0001	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KDR—breast cancer	1.02e-05	9.96e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MTOR—breast cancer	1.02e-05	9.96e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CB—breast cancer	1.02e-05	9.96e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—breast cancer	1.02e-05	9.95e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FN1—breast cancer	1.02e-05	9.94e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOTCH1—breast cancer	1.02e-05	9.94e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NFKBIA—breast cancer	1.01e-05	9.82e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOTCH1—breast cancer	9.96e-06	9.73e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APC—breast cancer	9.95e-06	9.72e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CG—breast cancer	9.95e-06	9.72e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KIT—breast cancer	9.95e-06	9.72e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ESR1—breast cancer	9.94e-06	9.71e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CD—breast cancer	9.88e-06	9.65e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGF—breast cancer	9.84e-06	9.6e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FN1—breast cancer	9.82e-06	9.59e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL8—breast cancer	9.8e-06	9.57e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ALB—breast cancer	9.75e-06	9.52e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APC—breast cancer	9.74e-06	9.51e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CG—breast cancer	9.74e-06	9.51e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KIT—breast cancer	9.74e-06	9.51e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—HRAS—breast cancer	9.74e-06	9.51e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NFKBIA—breast cancer	9.7e-06	9.47e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CDKN1B—breast cancer	9.65e-06	9.42e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGF—breast cancer	9.63e-06	9.4e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOTCH1—breast cancer	9.61e-06	9.38e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CDKN1B—breast cancer	9.57e-06	9.34e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—MAPK3—breast cancer	9.53e-06	9.31e-05	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AKT1—breast cancer	9.47e-06	9.24e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CG—breast cancer	9.4e-06	9.18e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APC—breast cancer	9.4e-06	9.18e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KIT—breast cancer	9.4e-06	9.18e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CASP3—breast cancer	9.38e-06	9.16e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL2—breast cancer	9.36e-06	9.14e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—BRAF—breast cancer	9.35e-06	9.13e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—NOS3—breast cancer	9.33e-06	9.11e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—MAPK3—breast cancer	9.33e-06	9.11e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—breast cancer	9.32e-06	9.1e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGF—breast cancer	9.29e-06	9.07e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—BRAF—breast cancer	9.16e-06	8.94e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCND1—breast cancer	9.13e-06	8.91e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CTNNB1—breast cancer	9.12e-06	8.9e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF1—breast cancer	9.11e-06	8.9e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—JUN—breast cancer	9.11e-06	8.89e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT2—breast cancer	9.1e-06	8.89e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—EGFR—breast cancer	9.07e-06	8.85e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CTNNB1—breast cancer	9.04e-06	8.83e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF1—breast cancer	8.92e-06	8.71e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT2—breast cancer	8.91e-06	8.7e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CDKN1A—breast cancer	8.91e-06	8.7e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTEN—breast cancer	8.89e-06	8.68e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—EGFR—breast cancer	8.87e-06	8.66e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP9—breast cancer	8.86e-06	8.65e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—BRAF—breast cancer	8.83e-06	8.62e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CDKN1A—breast cancer	8.83e-06	8.62e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTEN—breast cancer	8.81e-06	8.6e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CD—breast cancer	8.75e-06	8.54e-05	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CA—breast cancer	8.66e-06	8.46e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SERPINE1—breast cancer	8.65e-06	8.45e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAPK8—breast cancer	8.62e-06	8.42e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CB—breast cancer	8.61e-06	8.41e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF1—breast cancer	8.6e-06	8.4e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT2—breast cancer	8.6e-06	8.4e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AKT1—breast cancer	8.6e-06	8.39e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—KRAS—breast cancer	8.56e-06	8.36e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CD—breast cancer	8.56e-06	8.36e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—breast cancer	8.53e-06	8.33e-05	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CA—breast cancer	8.48e-06	8.28e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SERPINE1—breast cancer	8.47e-06	8.27e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—KRAS—breast cancer	8.38e-06	8.19e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CD—breast cancer	8.26e-06	8.07e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOS3—breast cancer	8.26e-06	8.07e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SRC—breast cancer	8.24e-06	8.05e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SRC—breast cancer	8.17e-06	7.98e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SERPINE1—breast cancer	8.17e-06	7.98e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOS3—breast cancer	8.09e-06	7.89e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—breast cancer	7.96e-06	7.77e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—STAT3—breast cancer	7.95e-06	7.76e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STAT3—breast cancer	7.88e-06	7.69e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CA—breast cancer	7.87e-06	7.68e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MDM2—breast cancer	7.84e-06	7.65e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RAF1—breast cancer	7.81e-06	7.63e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOS3—breast cancer	7.8e-06	7.62e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RELA—breast cancer	7.78e-06	7.59e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ERBB2—breast cancer	7.73e-06	7.54e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CA—breast cancer	7.7e-06	7.52e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MDM2—breast cancer	7.67e-06	7.49e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RAF1—breast cancer	7.64e-06	7.46e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CB—breast cancer	7.62e-06	7.44e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MTOR—breast cancer	7.62e-06	7.44e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RELA—breast cancer	7.61e-06	7.43e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MAPK3—breast cancer	7.59e-06	7.41e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ERBB2—breast cancer	7.56e-06	7.38e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAPK3—breast cancer	7.53e-06	7.35e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MTOR—breast cancer	7.46e-06	7.29e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CB—breast cancer	7.46e-06	7.29e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTEN—breast cancer	7.44e-06	7.27e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MDM2—breast cancer	7.4e-06	7.23e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MYC—breast cancer	7.38e-06	7.21e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RAF1—breast cancer	7.38e-06	7.2e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TGFB1—breast cancer	7.37e-06	7.19e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RELA—breast cancer	7.34e-06	7.17e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL8—breast cancer	7.33e-06	7.15e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MYC—breast cancer	7.32e-06	7.15e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TGFB1—breast cancer	7.3e-06	7.13e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ERBB2—breast cancer	7.3e-06	7.12e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—HRAS—breast cancer	7.28e-06	7.11e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EGFR—breast cancer	7.22e-06	7.05e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MTOR—breast cancer	7.2e-06	7.03e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CB—breast cancer	7.2e-06	7.03e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL8—breast cancer	7.17e-06	7e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EGFR—breast cancer	7.16e-06	6.99e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CDKN1B—breast cancer	7.16e-06	6.99e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—HRAS—breast cancer	7.13e-06	6.96e-05	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AKT1—breast cancer	7.08e-06	6.91e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CASP3—breast cancer	7.01e-06	6.85e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN1B—breast cancer	7e-06	6.84e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL2—breast cancer	7e-06	6.84e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—breast cancer	6.97e-06	6.8e-05	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AKT1—breast cancer	6.93e-06	6.76e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL8—breast cancer	6.92e-06	6.76e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CASP3—breast cancer	6.86e-06	6.7e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL2—breast cancer	6.85e-06	6.69e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCND1—breast cancer	6.83e-06	6.67e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—KRAS—breast cancer	6.82e-06	6.66e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—breast cancer	6.82e-06	6.66e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—JUN—breast cancer	6.81e-06	6.65e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KRAS—breast cancer	6.77e-06	6.61e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CTNNB1—breast cancer	6.76e-06	6.6e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN1B—breast cancer	6.76e-06	6.6e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCND1—breast cancer	6.68e-06	6.52e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—JUN—breast cancer	6.67e-06	6.51e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP9—breast cancer	6.63e-06	6.47e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CASP3—breast cancer	6.62e-06	6.47e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CTNNB1—breast cancer	6.62e-06	6.46e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL2—breast cancer	6.61e-06	6.46e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CDKN1A—breast cancer	6.6e-06	6.45e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTEN—breast cancer	6.59e-06	6.43e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP9—breast cancer	6.49e-06	6.33e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN1A—breast cancer	6.46e-06	6.31e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTEN—breast cancer	6.45e-06	6.3e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCND1—breast cancer	6.45e-06	6.29e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAPK8—breast cancer	6.45e-06	6.29e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—JUN—breast cancer	6.43e-06	6.28e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AKT1—breast cancer	6.43e-06	6.28e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CTNNB1—breast cancer	6.38e-06	6.23e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAPK8—breast cancer	6.31e-06	6.16e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKT1—breast cancer	6.29e-06	6.14e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CA—breast cancer	6.27e-06	6.12e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP9—breast cancer	6.26e-06	6.11e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN1A—breast cancer	6.24e-06	6.09e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTEN—breast cancer	6.22e-06	6.08e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CA—breast cancer	6.22e-06	6.07e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SRC—breast cancer	6.11e-06	5.97e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAPK8—breast cancer	6.09e-06	5.94e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—breast cancer	6.01e-06	5.87e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SRC—breast cancer	5.98e-06	5.84e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—breast cancer	5.95e-06	5.81e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STAT3—breast cancer	5.89e-06	5.75e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—breast cancer	5.83e-06	5.69e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HRAS—breast cancer	5.8e-06	5.66e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SRC—breast cancer	5.77e-06	5.63e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STAT3—breast cancer	5.77e-06	5.63e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HRAS—breast cancer	5.75e-06	5.62e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAPK3—breast cancer	5.63e-06	5.5e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—breast cancer	5.62e-06	5.49e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STAT3—breast cancer	5.56e-06	5.43e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—breast cancer	5.55e-06	5.42e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAPK3—breast cancer	5.51e-06	5.38e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—breast cancer	5.5e-06	5.37e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MYC—breast cancer	5.48e-06	5.35e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TGFB1—breast cancer	5.46e-06	5.33e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MYC—breast cancer	5.36e-06	5.23e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGFR—breast cancer	5.36e-06	5.23e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TGFB1—breast cancer	5.35e-06	5.22e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAPK3—breast cancer	5.32e-06	5.19e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CA—breast cancer	5.25e-06	5.13e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGFR—breast cancer	5.24e-06	5.12e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MYC—breast cancer	5.17e-06	5.05e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TGFB1—breast cancer	5.16e-06	5.04e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT1—breast cancer	5.12e-06	5e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT1—breast cancer	5.08e-06	4.96e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KRAS—breast cancer	5.06e-06	4.94e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGFR—breast cancer	5.06e-06	4.94e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KRAS—breast cancer	4.95e-06	4.84e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KRAS—breast cancer	4.78e-06	4.67e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CA—breast cancer	4.65e-06	4.54e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CA—breast cancer	4.55e-06	4.44e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—breast cancer	4.5e-06	4.39e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—breast cancer	4.4e-06	4.3e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CA—breast cancer	4.39e-06	4.29e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HRAS—breast cancer	4.3e-06	4.2e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AKT1—breast cancer	4.29e-06	4.19e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—breast cancer	4.25e-06	4.15e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HRAS—breast cancer	4.21e-06	4.11e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—breast cancer	4.12e-06	4.02e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HRAS—breast cancer	4.06e-06	3.97e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—breast cancer	4.03e-06	3.93e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—breast cancer	3.89e-06	3.8e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT1—breast cancer	3.8e-06	3.71e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT1—breast cancer	3.72e-06	3.63e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT1—breast cancer	3.59e-06	3.5e-05	CbGpPWpGaD
